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Abstract: The killer phenomenon is defined as the ability of some yeast to secrete toxins that
are lethal to other sensitive yeasts and filamentous fungi. Since the discovery of strains of
Saccharomyces cerevisiae capable of secreting killer toxins, much information has been gained regarding
killer toxins and this fact has substantially contributed knowledge on fundamental aspects of cell
biology and yeast genetics. The killer phenomenon has been studied in Pichia membranifaciens for
several years, during which two toxins have been described. PMKT and PMKT2 are proteins of low
molecular mass that bind to primary receptors located in the cell wall structure of sensitive yeast
cells, linear (1→6)-β-D-glucans and mannoproteins for PMKT and PMKT2, respectively. Cwp2p
also acts as a secondary receptor for PMKT. Killing of sensitive cells by PMKT is characterized by
ionic movements across plasma membrane and an acidification of the intracellular pH triggering
an activation of the High Osmolarity Glycerol (HOG) pathway. On the contrary, our investigations
showed a mechanism of killing in which cells are arrested at an early S-phase by high concentrations
of PMKT2. However, we concluded that induced mortality at low PMKT2 doses and also PMKT
is indeed of an apoptotic nature. Killer yeasts and their toxins have found potential applications
in several fields: in food and beverage production, as biocontrol agents, in yeast bio-typing, and as
novel antimycotic agents. Accordingly, several applications have been found for P. membranifaciens
killer toxins, ranging from pre- and post-harvest biocontrol of plant pathogens to applications during
wine fermentation and ageing (inhibition of Botrytis cinerea, Brettanomyces bruxellensis, etc.).
Keywords: Pichia membranifaciens; PMKT; PMKT2; killer toxin; biochemical characteristics;
mechanism of action; biocontrol; applications
1. Introduction
Killer yeast strains have the characteristic of secreting toxins of proteinaceous nature that are lethal
to sensitive yeast cells and filamentous fungi. The killer phenomenon in yeasts was first discovered
in Saccharomyces cerevisiae [1] but soon shown to be present in many other genera of yeast [2–4].
Until now, the killer phenomenon has been discovered in almost one hundred species of more than
twenty genera [5]. Over 11 different killer toxins have been described, and they are produced by representatives
of such genera as Hanseniaspora, Pichia, Saccharomyces, Torulaspora, Ustilago, Williopsis, etc. (Table 1) [6–10].
Killer yeasts are widespread in nature where they can be found in percentages that several fold exceed
those found in laboratory strains, indicating the existence of a competitive advantage. Microbes
have evolved to compete over the neighborhoods of their same niche. One of the mechanisms to
gain advantage that have been described is shown by some killer yeast through the presence of
dsRNA viruses. These mycoviruses encode killer toxins that provide benefits to the producing
cells by killing sensitive yeast cells. Killer toxin production has been related in S. cerevisiae with the
presence of two dsRNA viruses: L-A, the helper virus, and the M killer virus that encodes a killer toxin that
determines its phenotype (K1, K2, K28 or Klus). Although killer toxins could imply an important competitive
advantage, it has also been demonstrated that there is a fitness cost for carrying mycoviruses [11].
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In addition to the cytoplasmic dsRNA viruses mentioned above, a variety of yeast species
(Kluyveromyces lactis, P. acaciae, P. inositovora, D. robertsiae, Trichosporon pullulans, etc.) produce linear
dsDNA plasmids, probably not encapsulated, that encoded killer toxins. Furthermore, chromosomally
encoded killer toxins (Williopsis saturnus, Pichia anomala, Pichia kluyveri, Pichia membranifaciens, etc.) are
also found widespread in nature. Most of these toxins exceed the focus of the presented review but
their characteristics and potential applications can be reviewed in the tables showed (Tables 1–3).
The reasons why killer yeasts are immune to their own toxins remain to be elucidated for
most killer systems. However, in particular cases it has been solved. For example, K28 immunity
occurs via the ubiquitination of re-internalized mature toxin and unprocessed precursor moieties
complexes that are degraded by the proteasome [12]. Furthermore, Pichia acaciae, Kluyveromyces lactis
and Debaryomyces robertsiae cytoplasmic virus like elements encode toxic anticodon nucleases along
with specific proteins that confer toxin immunity [13,14]. The potential use of killer yeasts and their
toxins has been intended for various fields of application such as the alcohol fermentation industries
(brewery, winery, and distillery), fermented vegetables, biological control of post-harvest diseases,
yeast bio-typing, as antimycotics in the medical field and they have been used as model systems to
understand eukaryotic polypeptide processing and expression of eukaryotic viruses [10–21].
Currently, around 1500 different species of yeasts are known [22] and one of the largest yeast
genera is the genus Pichia within the context of number of species. The number of species included in
Pichia genus has changed considerably since Hansen (1904) first described the genus Pichia [22–25].
Pichia species are widely distributed and are present in natural habitats and also as spoilage yeasts in
several foods and beverages [26,27] and even, human pathogens [28,29].
Killer phenomenon has been discovered and studied in several species of Pichia that show killer activity
against yeasts or fungi of clinical concern (Table 2). Toxins of the genus Pichia are either associated with
cytoplasmic genetic elements, such as dsDNA virus-like elements or chromosomally encoded [30–32].
Gene products of both extranuclear and chromosomally encoded toxins, are diverse in their molecular
mass. There has been described monomeric toxins of Pichia species from less than 3 kDa (P. ohmeri killer toxin)
to trimeric toxins of more than 187 KDa (P. acaciae PaT) [29,33,34], although, similar to what occurs
globally for killer toxins, the molecular mass is not generally high (20–50 KDa) in Pichia toxins.
The stability of most killer toxins has been shown to be restricted to acidic pH values and low
temperatures [35–38]. In this regard, toxins of the Pichia genus are not different from the rest of
killer toxins; to date, no Pichia toxins with stability to high temperature or wide pH ranges have been described.
Known killer toxins display diverse modes of actions, such as membrane-damaging agents,
glucanase activity, inhibitors of β-1,3-glucansynthase, cell cycle arrest, inhibition of calcium uptake, or
tRNase activity; and toxins of the Pichia genus exhibit most of them [39–42].
In initial works, it was found that the majority of yeasts isolated from spontaneously fermenting
olive brines possessed the killer character and that strains of Pichia membranifaciens, the dominant
species, were particularly active in the presence of salt, eventually influencing the development of some
spontaneous fermentations [43,44]. The reasons for such an increased killer activity was elucidated
in the study of the mechanism of action of the first P. membranifaciens toxin analyzed, called PMKT
(produced by the strain CYC 1106). Additional studies indicated that P. membranifaciens CYC 1086,
presented a different killer behavior, secreting PMKT2. This review is about the killer system of
P. membranifaciens; and in particular, it focuses in the findings described during the last 20 years about
PMKT and PMKT2, until now, the only toxins described for this species. Significant progress in the
determination of the nature of the killer toxins, their toxic mechanism and approaches for the potential
use of such toxins has only been done very recently. In this review, are concentrated the studies carried
out for the characterization on PMKT and PMKT2, their primary and secondary receptors in sensitive
strains, toxin mechanisms of action, and cellular responses of sensitive cells to killer toxins. Finally, the
potential applications and future perspectives of killer toxins, with special focus in P. membranifaciens
killer toxins, are described and discussed.
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Table 1. Characteristics of killer toxins from genus other than Pichia.
Killer Yeast Strain (Killer Toxin) MolecularMass (kDa)
Glycoprotein
Nature Genetic Basis
Primary
Receptors Mode of Action References
Candida nodaensis PYCC 3198 (CnKT) - No Chromosome - - [45]
Debaryomyces robertsiae CBS6693 (-) >100.0 dsDNA (pWR1ApWR1B) Chitin - [46]
Hanseniaspora uvarum 470 (-) 18.0 No dsRNA (1→6)-β-D-glucans - [47]
Kluyveromyces lactis IFO1267 (Zymocin)
α (97.0);
β (31.0);
γ (28.0)
Yes (α), No (β, γ) dsDNA (pGKL1) Chitin <β2> rRNA fragmentation [48]
Kluyveromyces phaffii DBVPG 6076 (KpKt) 33.0 Yes Chromosome (1→6)-β-D-glucans;(1→3)-β-D-glucans Glucanase activity [49]
Saccharomyces cerevisiae
KL88
(K1)
α (9,5);
β (9.0) No M1-dsRNA (1→6)-β-D-glucans
Ionic channels formation in
plasma membrane [50]
-
(K2)
α (21.0);
β (5.0) Yes M2-dsRNA (1→6)-β-D-glucans
Increase in plasma
membrane permeability [51,52]
CBS8112
(K28)
α (10,5);
β (11.0) Yes M28-dsRNA Mannoproteins
Toxin entry by endocytosis and
cell cycle arresting in S phase [53]
-
(Klus) α (?), β (?) Yes Mlus-dsRNA - - [54]
111
(KHR) 20.0 - Chromosome - - [55]
-
(KHS) 75.0 - - -
Increase of membrane
permeability to ions [3]
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Table 1. Cont.
Killer Yeast Strain (Killer Toxin) MolecularMass (kDa)
Glycoprotein
Nature Genetic Basis
Primary
Receptors Mode of Action References
Schwanniomyces occidentalis ATCC 44252(-)
α (7.4);
β (4.9) No Chromosome Mannoproteins Plasma membrane damage [36]
Ustilago maydis
P1
(KP1) (19.0) α, β - dsRNA (P1) -
Increase of membrane
permeability to ions [56]
P2
(KP2) 11.1 - - -
Increase of membrane
permeability to ions [3]
P4
(KP4) 13.6 - dsRNA (P4) - Inhibition of Ca
+ channels [57]
P6
(KP6)
α (8.6);
β (9.1) - dsRNA (P6) - K
+ depletion [58]
Williopsis saturnus var. mrakii IFO 0895(HM-1) 10.7 No Chromosome
(1→6)-β-D-glucans;
(1→3)-β-D-glucans
Inhibition of
b-1,3-glucan synthase [59,60]
Williopsis saturnus var. saturnus IFO 0117(HYI) 9.5 No Chromosome -
(1→3)-b-D-glucans
sintase inhibition [61,62]
Zygosaccharomyces bailii 412(KT412) 10.0 No dsRNA Mannoproteins Plasma membrane damage [63]
Torulaspora delbrueckii
Kbarr
(Kbarr-1)
α (?),
β (?), γ (?) Yes dsRNA - - [64]
NPCC 1033 (TdKT) >30.0 - - (1→3)-β-D-glucans Cell wall disruption andapoptotic death processes [9]
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Table 2. Killer toxins from genus Pichia.
Killer Yeast Strain/s (Killer Toxin) MolecularMass (kDa)
Glycoprotein
Nature Genetic Basis
Primary
Receptors Mode of Action Reference
P. acaciae NRRLY-18665 (PaT) α (110), β (39), γ (38) Yes dsDNA (pPac1-2) Chitin Cell cycle arrest in G1,chitinase activity [30]
P. anomala
NCYC434
(Panomycocin) 49.0 Yes ? (1→3)-β-D-glucans
(1→3)-β-D-glucan
hydrolysis [65]
ATCC 96603/K36/
UP25F (PaKT) 85.0 - Chromosome β-Glucan - [66]
DBVPG 3003 (Pikt) 8.0 - Chromosome (1→6)-β-D-glucans - [67]
YF07b (-) 47.0 - Chromosome - (1→3)-β-D-glucanaseactivity [68]
VKM-Y (WAKTa/b) - - - - - [69]
P. farinosa KK1(SMKT) α (6.6), β (7.9) Yes Chromosome -
Membrane
permeabilization [70]
P. inositovora NRRL Y-18709 (-) 3 subunits > 100.0 - dsDNA (pPin1-3) Chitin rRNA fragmentation [71]
P. kluyveri 1002 (-) 19.0 Yes Chromosome -
Membrane
permeabilization [37]
DBVPG 5826 (Pkkp) 54.0 - - Cell wall receptor - [8]
P. kudriavzevii RY55 (-) 39.8 - - - - [72]
P. membranifaciens CYC 1106 (PMKT) 18.0 No Chromosome (1→6)-β-D-glucans
Membrane
permeabilization/apoptosis [19,41,73–76]
CYC 1086 (PMKT2) 30.0 - - Mannoproteins Cell cycle arrest/apoptosis [20,38]
Pichia ohmeri 158 (-) <3.0 - Chromosome - Loss of cellular integrity [33]
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2. Isolation of Pichia membranifaciens Killer Strains
The frequency and distribution of yeasts in fermentations of several olive brines is well
referenced [77,78], but investigations have habitually been related with negative effects [79–81]. Scarce
relevance has been given to the potential positive roles that most significant yeast species can develop
in olive brines, including interactions among different yeast species and with other microorganisms,
particularly the predominant bacterial populations responsible for the lactic acid fermentation of
olives. The majority of yeasts isolated from olive brines bore the killer character, and the strains of
P. membranifaciens, the dominant species, were found to be particularly active [43,82]. In this anthropic
environment, halotolerant yeast populations develop [43] at pH values around 4.5 and temperatures
that have been observed to be compatible with the killer character shown by most yeast isolates of such
environments. The presence of NaCl, in concentrations similar to that found in olive brines, increase
the killer character and augment the killer spectra of yeasts isolated from this environment, assessing
the relevance of the killer phenomenon and indicating that the killer character could be a competitive
advantage in this environment [44]. Furthermore, the presence of killer yeast in olive brines is found
to be very high (39%), indicating that, in these particular fermentative conditions, the killer character
could be particularly relevant for competition [83].
The isolated P. membranifaciens strains were screened against a collection of several sensitive
strains, for the presence of different P. membranifaciens killer phenotypes, determining the presence of,
at least, two clearly different ones [20] and confirming the fact that different toxins can be produced
by strains of the same yeast species. Two strains of P. membranifaciens, CYC 1106 and CYC 1086, were
selected because of their different killer spectrum of resistance/sensitivity and their higher activity
against the panel of potentially sensitive yeasts used. In conclusion, the strains of P. membranifaciens of
our laboratory produced two different toxins that were named PMKT (secreted by P. membranifaciens
CYC 1106) and PMKT2 (secreted by P. membranifaciens CYC 1086). These toxins are the main objective
of the investigations recovered in the present work.
3. Production of PMKT and PMKT2
Having established that the secreted toxins increased in culture liquid as growth progressed and
then stabilized when the yeast population reached the stationary phase (as considered for primary
metabolites), the toxins of P. membranifaciens were purified from samples taken at the early stationary
phase, where the toxins concentration was observed to be higher [84]. The production of killer toxins
in complex media (which contained peptone, malt extract and yeast extract) and minimal media
(containing growth factors, mineral salts and trace elements) has been compared. Although production
of PMKT in complex media is higher than in minimal media, the specific activity is higher (seven-fold
higher) in the latter case, according to similar observations that were reported previously [85,86] and
probably due to the greater stability of the toxin in a media with high contain in peptides and proteins.
However, for the purpose of PMKT2 production and purification, P. membranifaciens CYC 1086 is
developed in complex medium because PMKT2 is purified easier [20,39].
In addition, with the aim of increasing toxin production, stabilizing agents such as polyols,
detergents and protease inhibitors were added. Results indicated that the non-ionic detergents,
in particular Brij-58, increased the killer activity present in the extracellular media after growth.
Accordingly, the synthetic medium with Brij-58, was used for purification of PMKT [19]. Probably,
non-ionic detergents stabilize the killer toxin produced or inhibit the adsorption by (1→6)-β-D-glucans.
(1→6)-β-D-glucans in yeast cell walls are known to function as primary receptors of some killer
toxins in sensitive cells [47,49–52,59,75,87]. Killer cells have these (1→6)-β-D-glucans, and it is easy to
understand that some amount of the secreted toxins can be attached by (1→6)-β-D-glucans and are
not released to the culture medium. The same can be applied to KRE1 mutants, which show a 50%
reduction in cell wall (1→6)-β-D-glucans that are superkillers due to an increased secretion of the K1
toxin of S. cerevisiae [88].
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Production of toxins by killer yeasts with an increased degree of activity also depends on the
culture conditions of pH and temperature. Briefly, the maximum killer toxin production for both
toxins was achieved at acidic pH values of around 4.5 at 20 ◦C, accordingly to the activity and stability
properties described later in this review for both toxins.
4. Homogeneity Purification and Biochemical Characterization of PMKT and PMKT2
The homogeneity purification of the killer toxins of P. membranifaciens, as well as other proteins
and enzymes, depends, not only on the characteristics of the killer toxin, but also on the complexity of
the protein extract from where they have to be purified. Furthermore, both the well-reported lability
of secreted toxins from killer yeasts and their aggregation tendency are usual problems found during
killer toxin purification, especially in the case of PMKT [19,20]. Accordingly, in spite of the similar
biochemical characteristics of PMKT and PMKT2, the purification of both toxins is achieved using
different approaches. PMKT is purified from P. membranifaciens CYC 1106 in four steps and being
necessary the use of an affinity column of (1→6)-β-D-glucan-epoxy-Sepharose 6B [19] whereas PMKT2
is easily purified to homogeneity from P. membranifaciens CYC 1086 [20]. Biochemical characteristics of
PMKT and PMKT2 have been determined.
Both toxins are observed to be monomeric non-glycosylated proteins of 18 kDa (PMKT) and 30 kDa
(PMKT2) with isoelectric points of around 3.9 for PMKT and 3.7 for PMKT2. In addition, both toxins
are found to be similar in their behavior at different pH and temperature values. Protein denaturation
involves changes in protein structure (generally an unfolding) with the loss of activity. The stability of
most killer toxins has been shown to be strongly dependent on acidic pH values (pH < 5.5–6.0) and
low temperatures (<20–25 ◦C), and mechanical shaking is also destructive [35–38]. PMKT is stable
only within a pH interval of 3.0 and 4.8 and it is rapidly inactivated at temperatures above 20 ◦C, in
accordance with the loss of PMKT production during yeast growth in pH and temperatures above
these values [19,20]. PMKT2 had physical chemical properties similar to PMKT: it was active at acidic
pH values (2.5–4.8) and temperatures below 20 ◦C, although, it was less labile during short periods
of time at higher temperatures and neutral pH values than PMKT. However, differences in these
properties between killer toxins indicate that they are biochemically distinct [38,89]. In this regard,
HM-1 killer toxin, produced by W. saturnus var. mrakii IFO0895 (previously named as Hansenula mrakii)
is special in its wide range of stability to pH and temperature, as it remains active after exposure to
100 ◦C for 10 min and pH values comprised between 2 and 11 [59,90]. Probably, the observed internal
disulfide bridges give to this toxin its higher stability [91,92]. Tilletiopsis albenscens killer toxin seems to
be stable in a broad pH range of 3.5–8.0 [93].
5. Killing Mechanism of Action
5.1. Primary Receptors in Sensitive Yeast Cells
It is widely accepted that cell surface polysaccharides act as receptors for bacteria, viruses, and
toxins [52,94]. Yeast killer toxins have different mechanisms of action but most toxins are able to kill
sensitive yeasts in a two-step process that is receptor-mediated. There are two kinds of killer toxin
receptors: the primary, usually located on the cell wall, and the secondary receptor, that exist on the
plasma membrane of the sensitive cells. The interaction with the first receptor within the cell wall of
a sensitive target cell involves a fast and energy-independent binding [20,49,75,76,95–99]. Cell walls
are mainly composed by carbohydrates, some of them free and some linked to proteins. Overall, the
main components of the yeast cell wall are (1→3)-β-D-glucans, (1→6)-β-D-glucans, mannoproteins
and chitin, which is concentrated in the bud-scar region [100,101].
A diversity of cell wall receptors for killer toxins exist, evidencing that all the main cell wall
components of yeasts could function as the primary receptor for a killer toxin. For example,
(1→6)-β-D-glucans act as cell wall receptors for K1 and K2 killer toxins of S. cerevisiae [44,52], for
Hanseniaspora uvarum killer toxin [102] and for Pichia anomala DBVPG3003. (1→3)-β-D-glucans are
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primary receptors for Pichia anomala NCYC434 [65], mannoproteins are receptors for KT28 of S. cerevisiae
and also Zygosaccharomyces bailii killer toxin [63,96,103,104], and, finally, chitin is the cell receptor for
Kluyveromyces lactis killer toxin [97]. In agreement with that, reported mutations in a gene/genes
involved in the synthesis or architecture of the cell wall are observed to be resistant to killer toxins.
Kre-Killer Resistant mutants have been obtained for K1 [105] and, in the same way, mnn-Mannoprotein
mutants for K28 [106]. Mutational analyses revealed that both subunits of K1, α and β, are involved in
glucan binding [107,108]. It has been indicated that the primary receptors in the cell wall facilitate the
primary contact of the killer toxins with the sensitive yeasts or even mediates close contacts between
the toxin and secondary receptors on the plasma membrane [96].
Using both in vivo and in vitro approaches, in previous works [75], it was confirmed the role
of (1→6)-β-D-glucans as primary targets for PMKT and the utility of such interaction as an effective
means for PMKT purification [19]. Finally, it was shown that the adsorption of PMKT to purified
(1→6)-β-D-glucans occur within the first 2 min of contact, indicating, as previously hypothesized,
that this process is an energy-independent binding and toxin-specific, since polysaccharides with the
following linkages: (1→3)-β-, (1→4)-β-, (1→4)-α-, or (1→6)-α- were unable to bind PMKT.
Yeast mannans may be covalently linked to cell wall proteins, so that the term “mannoproteins”
adequately reflects their status in the yeast cell wall. Mannoproteins have been described as antigenic
determinants, also functioning as receptors or even as support for other receptors of different
nature [109,110]. Conversely to what was found for PMKT, in a complementary study for the
determination of the binding capacity of different yeast cell-wall fractions, cell wall glucan fractions
do not bind PMKT2, whereas mannoproteins and mannan purified from sensitive yeasts were able to,
showing the existence of a cell wall receptor of different nature for PMKT2 [20].
5.2. Secondary Receptors for P. membranifaciens Killer Toxins
It has been described that, for most toxins, a second step that implies toxin transfer to the plasma
membrane and subsequent bind to the secondary receptor mediates killing. The number of studies
conducted for the determination of the presence and description of secondary receptors are scarce.
However, the evidences accumulated during years of investigation about the effects of killer toxins on
sensitive yeast cells corroborated that, in addition to primary receptors, specific and essential secondary
receptors should be involved in the killing mechanism. In the case of K1 toxin, the most studied killer
toxin, the resistance of whole cells of kre mutants to K1 and the sensitivity of the spheroplasts of kre
mutants and wild-type cells, indicate the existence of these secondary receptors [98,111]. K1 toxin, after
its binding to cell wall (1→6)-β-D-glucans [85], interacts with Kre1p, an O-glycosylated GPI-anchored
cell wall protein. Mutational analyses reveal that solely α subunit interacts with Kre1p. ∆KRE1
mutants show complete resistance to K1, indicating that Kre1p acts as a receptor in the cytoplasmic
membrane [21,98,99,103,112].
In addition, a few receptors for other toxins have been described. The H/KDEL receptor Erd2p
mediates K28 toxin binding and uptake in yeast spheroplasts, a viral A/B toxin bearing an HDEL
motif at the β-subunit. In vivo toxicity to K28 depends on the existence of Erd2p [113]. In the case
of Kluyveromyces lactis zymocin, Ipt1p seems to be involved as a membrane receptor. KTI6, which
is allelic to IPT1 (coding for mannosyl-diinositolphospho-ceramide [M(IP)2C] synthase), join in a
step that follows recognition of the primary receptor (chitin) of the toxin but precedes the role of the
multi-subunit Elongator, involved in histone acetylation and transcription, the most probable toxin
target [114].
Speaking specifically about Pichia toxins, only the membrane receptor for the PMKT toxin has
been described. Some unidentified receptors have been hypothesized for other Pichia toxins, in an
attempt to explain the binding capability and sensitivity of toxin-treated spheroplasts [115,116]. PMKT
resembles K1 mechanism of action, using a similar strategy to reach the cytoplasmic membrane,
involving a two-step interaction with the primary receptors (1→6)-β-D-glucans) and cell wall-localized
secondary receptors which are also plasma membrane-associated. PMKT utilizes as the secondary
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membrane receptor a GPI-anchored protein of the cell wall [76]. This protein, called Cwp2p, can
be purified using PMKT-affinity chromatography, indicating the existence of an in vitro interaction
between both proteins. It was found, in a collection of 288 viable deletion mutants for proteins
related to the cell periphery, as appeared in the CYGD (Comprehensive Yeast Genome Database), that
15 ORFs increased protoplast resistance to the toxin when deleted. This agrees with the hypothesis that
Cwp2p is a secondary receptor for PMKT. Furthermore, complete yeast cells and cwp2∆ protoplasts
are resistant and also unable to bind PMKT, demonstrating once again that Cwp2p is necessary for
PMKT toxicity. In addition, it should be indicated that, in its definitive state, Cwp2p is bind to
(1→6)-β-D-glucans and this is the most probable way by which PMKT interact closely with Cwp2p,
the plasma membrane receptor located in the cell wall. It has been also demonstrated, using a
collection of deletion mutants related to GPI (Glycosyl Phosphatidyl Inositol) anchor biosynthesis,
that Cwp2p is present in both cellular locations the plasma membrane and cell wall, as usually
occur for most GPI-proteins of the yeast cell wall [76,98]. The fact that, when exposed to PMKT, GPI
anchoring-defective mutants are much more resistant, and so are protoplasts from wild-type strains
previously incubated with phosphatidylinositol-specific phospholipase C (to remove GPI-anchored
proteins), indicate that the precursor of Cwp2p, which is GPI-anchored, is involved in PMKT
mechanism of action. Furthermore, carboxyfluorescein-entrapped liposomes that include purified
Cwp2p are observed to release carboxyfluorescein in the presence of PMKT while liposomes without
Cwp2p do not. This is consistent with the idea that the presence of another effector is not necessary
in the proposed model. Cwp2p, could facilitate PMKT insertion into the plasma membrane bilayer,
as has been proposed for other toxin receptors [117,118] and in accordance to the observed effects in
PMKT-intoxicated cells [41]. The N-terminal amino acidic sequence of Cwp2p presents a PIR repeat
and, due to the presence of multiple serine and threonine residues, the rest of Cwp2p is O-glycosylated
and thus, probably bears several phosphodiester groups. At acidic pH values (those pH values where
there is killer activity), PMKT bears positive charges and so on could be strongly bound to the negative
charges present on Cwp2p [76]. Overall, data suggested that Cwp2p plays a central role in the activity
of PMKT, acting as a bridge between the primary receptors and the plasma membrane and promoting
cellular toxicity. Finally, after reaching the cytoplasmic membrane, PMKT exerts its toxin action by
cation channel formation and disruption of transmembrane gradients [41]. Until now, it has not been
possible to determine the existence of a secondary receptor for PMKT2.
5.3. Cellular Responses to Killer Toxins
5.3.1. PMKT
Many targets to the killer toxin action in sensitive cells have been identified and, in consequence,
some molecular mechanisms of killing action have been also determined. The first study for
determining some aspects of the killing action of PMKT was intended to assess the importance
of the addition of salt (which is common in the production of traditional fermented foods) in the
expression of the killer phenotype [44]. In preliminary studies, we observed that sodium chloride in
concentrations of up to 6% (wt/vol) eventually enhanced the toxicity and enlarged the killer spectra of
a few of the yeasts tested. This observation raised the question of whether this higher activity was
due to increased killer toxin production or increased sensitivity of the strains affected. In addition,
it has been also shown that the killing action of some other killer yeasts isolated from high salinity
environments are related on the presence of NaCl. For example, SMK toxin produced by Pichia farinosa
KK1 shows its maximum killer activity in the presence of 2.0 M NaCl [70]. Furthermore, CnKT,
produced by Candida nodaensis, presents a strong salt-dependent phenotype [45] and the same can also
be observed for Mrakia frigida 2E00797 and Williopsis saturnus WC91-2 killer toxins [119,120]. However,
so far, little has been studied concerning the reasons why, in these particular cases, the killing activity
is dependent on NaCl.
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PMKT finds its greatest similarity in K1, which share certain biochemical characteristics such
as similar isoelectric point and molecular mass. In a similar way to the mode of action in which K1
acts from outside the cell after reaching the cytoplasmic membrane, PMKT exerts its lethal effect by
ion channel formation and disruption of cytoplasmic membrane gradients [19,121–123]. PMKT binds
to the cell wall (1→6)-β-D-glucans in the first 2–3 min after toxin addition, and then a lag phase of
approximately one hour is necessary to observe reductions in cell viability, probably reflecting the time
necessary for the development of the mechanism of action, gradual intoxication and death. The lag
phase observed after cell wall binding and previously to cell death, is supposed to involve several
sequential interactions and effects: interaction with secondary receptors, ion channel formation in the
plasma membrane, alteration of transmembrane gradients and deenergization of cells and eventually,
formation of large unspecific plasma membrane pores that permit the passage of other intracellular
molecules [124]. During the first 30 min of incubation with PMKT, the pHi of toxin-treated sensitive
cells and control cells is observed to be similar, thereafter, pHi is progressively acidified, reaching
values of about 4.6–4.7 after 0.5–1 h incubation with PMKT. Then a leakage of K+ out of the cells starts
(1–1.5 h after exposure to PMKT) and simultaneously, a flow of Na+ began. In the same way as K+,
the intake of Na+ is directly related with killing [41]. The disruption of ionic equilibrium across the
cytoplasmic membrane may could generate an augmented mortality of the cells in the presence of
salt. The increased permeability of the cytoplasmic membrane to protons could consequently generate
the influx of ions through the plasma membrane. Any compound accumulated in or outside the cell
against its concentration gradient will equilibrate and a flow could occur. These findings are also in
agreement with those studies that observed in yeast spheroplasts and artificial liposomes treated with
K1 that the ion channels caused by K1 do not distinguish between Na+ and K+ [122,125].
In addition, PMKT causes in liposomes a conductance when added at low pH, showing a
characteristic channel activity. Furthermore, all the common physiological ions are observed to
flow through the pores caused by PMKT in the selectivity sequence: K+ > Na+ > Li+ > Ca2+ > Cl−.
Finally, changes in plasma membrane integrity (determined as permeability to propidium iodide) are
observed when cellular death was advanced in time, being probably a late consequence of PMKT
treatment [41].
Yeasts response to harsh physical chemical factors (oxidative stress, heat, osmotic shock, nutrient
availability, extreme pH, toxins, heavy metals, etc.) by activating a wide variety of defenses that
include general or specific regulatory pathways, activating multiple MAPK cascades, which transform
stimuli into appropriate physiological responses [126–128]. In order to confirm the physiological
events described for PMKT toxicity [41], the transcriptional response of the sensitive cells was studied
with a view to obtain information of the mechanisms of killing action. In addition, the results were
confirmed by studying the response of deleted mutants in all those genes that were observed to be
significantly up- or down-regulated when sensitive cells were treated with PMKT [73]. When the
global gene expression response of the yeast S. cerevisiae to PMKT was explored, 146 genes showed an
altered expression in response to PMKT.
PMKT-treated cells with a PMKT dosage of 1205 AU/mL (considered to be a high dose as stated
below) and untreated cells were selected for mRNA isolation and determination of the transcriptional
response. The most important functional group with 31 up-regulated genes is the group related to
signal transduction, gene expression, transcription and RNA processing, followed by the group of
genes related to ionic homeostasis, transport facilitation, carbohydrate metabolism, and cell stress and
rescue. Both, the phosphatases and dehydrogenases implicated in the glycerol production pathway
are also up-regulated in response to PMKT. In addition, many similarities are found when the group of
up-regulated genes in response to the toxin [73] and those induced by osmotic stress [129] are compared.
In fact, most PMKT-induced genes encode proteins involved in counteracting the physiological changes
induced by an osmotic shock, thus indicating the existence of an osmotic-related stimulus inside the
cells when treated with the toxin. Genes that were related to salt tolerance in response to PMKT were
CTT1, HSP12, GPD1, GPP2, TRK2, PDR12, ENA1, SCH9, HAL9, YAP1, XBP1, and STL1 (Figure 1).
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Furthermore, ENA1, TRK2, PHO89, ZRT1 and PDR12 are a group of genes that surely are found to
be up-regulated because of the leakage of ions and small metabolites induced by the toxin due to
the generation of non-specific channels in a cellular response to compensate the leakage over a short
period of time [41,73].
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Figure 1. Analysis of the transcriptional response of S. cerevisiae to PMKT. Genes, sorted into functional
categories, induced after a PMKT exposure by more than 3-fold and repressed by more than two-fold.
In S. cerevisiae, it is known that the response to rapid changes in the osmolarity relies in
the activation of the HOG (High Osmolarity Glycerol) pathway, which is manifested by the
phosphorylation of Hog1p. Hog1p encodes for the MAPK that is activated by phosphorylation
and then translocated to the nucleus to counteract with several environmental stimuli [130]. HOG1∆
mutants are hypersensitive to such environmental stresses, which cause Hog1p activation [130,131].
Several transcription factors have been found to be among the substrates of Hog1p [132], so the
phosphorylation and the consequent activation of Hog1p also regulates gene expression profiles [133].
Hog1p phosphorylation has been studied in order to determine whether the observed transcriptional
response in the presence of PMKT was connected with the HOG pathway or not [73]. Hog1p
phosphorylation is observed rapidly in PMKT-intoxicated cells. Phosphorylation is present in the
first ten minutes, and during the rest of the exposure to PMKT, indicating constant activation of the
signaling pathway. Accordingly, HOG1∆ mutants are found to be hypersensitive to PMKT.
Glycerol is the main compatible osmolyte that accumulate rapidly as a consequence of activation
of Hog1p and the transcriptional response is correlated with known responses to osmotic shocks.
The mRNA coding for enzymes, GPD1 and GPP2, involved in glycerol production, were augmented in
the presence of PMKT, agreeing with the glycerol increment observed in response to PMKT, clearly
revealing compatible osmolyte accumulation to counteract the toxin (Figure 2).
In conclusion, the most important number of up-regulated genes are core environmental stress
response genes, in relation with the HOG pathway, showing that the global transcriptional response
to PMKT is probably due to an alteration of the transmembrane gradients and so on cellular
homeostasis [41]. Deletion mutants of up-regulated genes in response to PMKT are also observed
to show hypersensitive phenotypes to PMKT, direct evidence that they are surely involved in the
mechanism of action of PMKT [73], an effect also observed in HOG signaling-defective cells of
S. cerevisiae when exposed to K1 [134], suggesting a response coincident to other hyperosmotic stresses
being effective to counteract K1 toxicity. However, GPD1∆mutants, and others defective in intracellular
glycerol production, are hypersensitive to PMKT, but this is not the case for K1 and no downstream
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effectors of Hog1p relevant for K1 resistance could be identified [134]. It has been described that, for
most toxins, a second energy-dependent step operates, involving toxin transference to the cytoplasmic
membrane and subsequent interaction with the secondary membrane receptor.Toxins 2017, 9, 112    11 of 26 
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Figure 2. Cellular response to P KT exposure deduced fro the analysis of the transcriptional
response of S. cerevisiae to t e toxin. Once PMKT has reached the cell wall t rough an interaction
with (1→6)-β-D-glucans, PMKT interacts with the cytoplasmic membrane through the interaction
with cw 2p (not shown in the figure). This interaction, t rough a mechanism of u known nature (?),
leads to disrupti n of electrochemical gradients. Cellular recepto s are not included in the scheme for
simplification. PMKT cause the formation of annels through which cations and small
metabolites (e.g , K+, H+, Na+ fl ese changes in pHi, turgor or ioni concentrations
gen rates a transcriptional response throu t ti ti of og1p. Genes (C T1, HSP12, HSP26,
and DDR2), related with a general stress respo se, a e es ( PD1 and G P2), involved in glycerol
synthesis, are transcribed to compensate the toxic effects of P KT. Cations and glycerol, among
others, can leak out from sensitive cells generating cell death. Highlighted in a box are the induction
levels of the most up-regulated genes. Abbreviations: DHAP (dihydroxyacetone phosphate), G3P
(glycerol-3-phosphate), FBP (fructose-1,6-bisphosphate), MG (methylglyoxal), CoQ (coenzyme Q),
S-LG (S-D-lactoylglutathione), GSH (glutathione).
5.3.2. PMKT2
The fact that PMKT2 presented a different spectrum of killer activity, as indicated above, soon
suggested that the molecular mechanism of action of PMKT2 might be different. In previous works [20],
the binding of PMKT2 to mannoproteins, its primary receptors, was seen to occur in the first two or
three minutes after PMKT2 incorporation and then, cellular viability reduced (80% after 5 h of exposure
to PMKT2). Furthermore, none of the cellular events observed, when sensitive cells are intoxicated
with PMKT, occurred with PMKT2. Leakage of +, Na+ influx and reduction of pHi were not observed
du ing the initial exposure to PMKT2, indicating that the nature of the interaction is not r lated
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with the formation of unregulated cation-permeable channels. The observed increase of membrane
permeability to H+, K+, Na+ after 4–5 h in contact with PMKT2 is considered an indirect effect, since
they initiate concomitantly or after cell death, reflecting that they are not primary effects.
The reason so many dead cells remain non-permeabilized during a long time of exposure to
PMKT2 was elucidated when the cell cycle was studied. Flow cytometry studies of sensitive yeast cells
exposed to PMKT2 show cells with arrested at an early S-phase with a nascent bud and pre-replicated
1n DNA content (Figure 3). The execution point for lethality was determined with more precision by
checking the sensitivity/resistance of cells arrested at different cell cycle stages. Alpha-factor-arrested
cells at the G1-phase or G2-phase-arrested cells by treatment with methyl benzimidazol-2-yl-carbamate,
are resistant to PMKT2, indicating that sensitive yeasts are not affected in these stages. Furthermore, in
both cases, sensitive cells rescued from the arrest are inhibited by the toxin, suggesting, all together,
that G2-phase-released cells start to divide, but die in the presence of the toxin after initiating the
S-phase, adopting a terminal phenotype. To explain the late ion movements across plasma membrane,
we hypothesize that, during the first moments of toxin action, the cell cycle arrest does not cause
cytoplasmic membrane permeabilization and then, the arrested cells became converted unviable and
plasma membrane permeabilization happens [42].
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of PMKT2 caused cell cycle arrest at G1/S. Flow cytometry analyses of DNA content of S. cerevisiae 
revealed that cells treated with high doses of PMKT2 were arrested at an early S phase with a nascent 
bud. (B) Asynchronously growing cells exposed to inactivated toxin remained fully viable. (C) Cells 
treated with low concentrations of PMKT2 lead to the typical markers of apoptosis. Figure adapted 
and reproduced with permission (Santos et al. 2013) [42]. 
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It has been described how the killing of S. cerevisiae sensitive cells by P. membranifaciens killer 
toxins may be expressed as a combination of two mechanisms depending on toxin dosage. High doses 
(between 1250 and 2000 AU/mL) of PMKT and PMKT2 are observed to induce the aforementioned 
effects on sensitive yeast cells. By contrast, low doses (200 AU/mL) of the toxins lead to a cell death 
process in S. cerevisiae accompanied by cytological and biochemical indicators of apoptotic cell death 
(PCD, Programmed Cell Death). The observed cell death process is characterized by the presence of 
an initial apoptotic state that rapidly evolves to a necrotic state. The rate at which this process occurs 
is proportional  to  the amount of killer  toxin used  in  the study. Low PMKT concentrations (up  to 200 
Figure 3. Mechanisms of the killing activity of PMKT2 depending on toxin dosage. (A) High
concentrations of PMKT2 caused cell cycle arrest at G1/S. Flow cytometry analyses of DNA content of
S. cerevisiae revealed that cells treated with high doses of PMKT2 were arrested at an early S phase with
a nascent bud. (B) Asynchronously growing cells exposed to inactivated toxin remained fully viable.
(C) Cells treated with low concentrations of PMKT2 lead to the typical markers of apoptosis. Figure
adapted and reproduced with permission (Santos et al. 2013) [42].
In short, the killing of action of PMKT, as well as several other yeast killer toxins, is related to
peptide membrane permeation properties [16,41,125], whereas the mechanism of PMKT2 is related to
cell cycle arrest [42].
5.4. The Dual Mechanism of Action of PMKT and PMKT2
It has been described how the killing of S. cerevisiae sensitive cells by P. membranifaciens killer
toxins may be expressed as a combination of two mechanisms depending on toxin dosage. High doses
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(between 1250 and 2000 AU/mL) of PMKT and PMKT2 are observed to induce the aforementioned
effects on sensitive yeast cells. By contrast, low doses (200 AU/mL) of the toxins lead to a cell death
process in S. cerevisiae accompanied by cytological and biochemical indicators of apoptotic cell death
(PCD, Programmed Cell Death). The observed cell death process is characterized by the presence
of an initial apoptotic state that rapidly evolves to a necrotic state. The rate at which this process
occurs is proportional to the amount of killer toxin used in the study. Low PMKT concentrations (up to
200 AU/mL) lead to a higher number of apoptotic cells, whereas higher concentrations (from 300
to 3000 AU/mL) cause both apoptosis and necrosis. Necrotic cells are usually characterized by a
permeabilized plasma membrane (usually detected by propidium iodide stain), whereas the plasma
membrane that have initiated a PCD phenotype is usually intact. As a result of these investigations,
it can be determined that cells appear to start the process of death with a PCD response, die as a
consequence of apoptosis, and then, as a late consequence, become necrotic [74]. In these experimental
conditions, cell death is characterized by cytological, genetic and biochemical indicators of apoptosis,
namely, an increment of reactive oxygen species (ROS), DNA strand breaks, externalization of
phosphatidylserine, metacaspase activation and cytochrome c release, confirming the hypothesis
of PCD induction.
It has been also demonstrated that the secondary receptors in the sensitive cells have the same
function in both experimental conditions. CWP2∆ mutants are resistant to pro-apoptotic, as well as for
pro-ionophoric amounts of PMKT, also in agreement with the observations obtained for Kre1p, the
plasma membrane secondary receptor involved in the K1 mechanism of action [76,135], indicating that
Cwp2p is always involved in the killing action [76,135].
In the comparison studies between the two experimental conditions, it has been determined
whether the transcriptional response of the cells is coincident. Therefore, using DNA microarrays,
global gene expression has been also evaluated in the presence of pro-apoptotic concentrations of
PMKT. The results obtained from DNA microarrays indicate that genes related with an oxidative stress
response are induced, showing that the transcriptional response is not coincident with that obtained
for pro-ionophoric doses of PMKT. The most highly induced genes are, in order, DCS2, FLR1, GSH1,
APH1, VPS13, TSA2, GLR1, ECM4, AAD14 and GTO3, most of which are observed to be induced by
different oxidative compounds. Several genes encoding for ROS detoxifying enzymes, such as CTT1,
PRX1, TSA1, and SOD1, are also observed to be up-regulated (activations comprised between +16.1
and +11.3), indicating an oxidative stress that can be observed by analyzing the ROS production with
dihydroethidium in the presence of PMKT (Figure 4).
Taking into account the previous research on PMKT, we raised the possibility that PMKT2 also
presented the aforementioned duality in its mode of action. This hypothesis was confirmed following
the same experimental approach used for PMKT. Briefly, we described how the mechanism of killing of
S. cerevisiae cells may be expressed as a sum of two mechanisms that depend on the used PMKT2 doses.
High doses induce cell cycle arrest as already mentioned and low doses, as well as described for PMKT,
induced a PCD process accompanied by cellular and genetic indicators of PCD in S. cerevisiae [42].
It remains to be determined why low concentrations of both toxins, PMKT and PMKT2, alter the
oxidative homeostasis of sensitive cells and cause apoptosis (Figure 5). The mechanism by which PCD
is induced in response to P. membranifaciens toxins, as other killer toxins, is as yet unknown, but it
proves to be a challenging research field for the future.
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Figure 4. Transcriptional response of S. cerevisiae after exposure to pro‐apoptotic concentrations of 
PMKT. Respiratory chain of S. cerevisiae with the indication of sites where ROS are formed and the 
main mitochondrial  enzymes  involved. Numbers  indicate  the  levels  of  induction  of  some  genes 
coding for such representative enzymes. Figure adapted and reproduced with permission (Santos et al. 
2011) [74]. 
Figure 4. Transcriptional response of S. cerevisiae after exposure to pro-apoptotic concentrations of
PMKT. Respiratory chain of S. cerevisiae with the indication of sites where ROS are formed and the main
mitochondrial enzymes involved. Numbers indicate the levels of induction of some genes coding for
such representative enzymes. Figure adapted and reproduced with permission (Santos et al. 2011) [74].
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reproduced with permission (Santos et al. 2011; Santos et al. 2013) [42,74]. 
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Although killer toxins were originally described and studied for their ecological function in the early 
1960s  [1], and  they promptly  received much attention  from geneticists  for  the understanding of  their 
genetic basis at the end of this decade [86,136], their biocidal nature has an inherent applicability in 
clinical, food and biocontrol fields that was not systematically explored until the 1990s (for medicine: 
[137–139];  for  food:  [140–143];  for  biocontrol:  [144–146]).  As  mentioned  at  the  beginning,  P. 
membranifaciens killer yeasts exhibit a broad action  spectrum  including yeasts of biotechnological 
concern  (Brettanomyces/Dekkera,  Candida  boidinii,  Zygosaccharomyces)  and  phytopatogenic  fungi 
(Fusarium proliferatum, Botrytis cinerea), as well as other killer yeasts [21,104]. 
To a large extent, the potential applications that have been proposed for yeast killer toxins have been 
conditioned by  the aforementioned  recognized  lability of such  toxins. The proposed applications  are 
largely restricted to those that provide physical chemical conditions compatible with the stability of 
killer toxins, that is, those that can be performed at relatively low pH and low temperature values 
(Table 3). Although  the majority of killer  toxins  (W. mrakii var. mrakii HM‐1, W. saturnus  toxin, P. 
anomala PaKT and Z. bailii zygocin) have shown activity against pathogenic yeasts, such as Candida 
albicans, Cryptococcus neoformans, etc., they have been suggested to be potentially useful as potential 
antifungal agents for infections caused by fungi, their direct application is of limited real importance 
Figure 5. Schematic representation of the most important events known to be induced in S. cerevisiae
after exposure to high [↑] and low [↓] concentrations of PMKT and PMKT2. Figure adapted and
reproduced with permission (Santos et al. 2011; Santos et al. 2013) [42,74].
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6. Applications, Conclusions and Future Perspectives of P. membranifaciens Killer Toxins
Although killer toxins were originally described and studied for their ecological function in the
early 1960s [1], and they promptly received much attention from geneticists for the understanding
of their genetic basis at the end of this decade [86,136], their biocidal nature has an inherent
applicability in clinical, food and biocontrol fields that was not systematically explored until the 1990s
(for medicine: [137–139]; for food: [140–143]; for biocontrol: [144–146]). As mentioned at the beginning,
P. membranifaciens killer yeasts exhibit a broad action spectrum including yeasts of biotechnological
concern (Brettanomyces/Dekkera, Candida boidinii, Zygosaccharomyces) and phytopatogenic fungi
(Fusarium proliferatum, Botrytis cinerea), as well as other killer yeasts [21,104].
To a large extent, the potential applications that have been proposed for yeast killer toxins have
been conditioned by the aforementioned recognized lability of such toxins. The proposed applications
are largely restricted to those that provide physical chemical conditions compatible with the stability
of killer toxins, that is, those that can be performed at relatively low pH and low temperature values
(Table 3). Although the majority of killer toxins (W. mrakii var. mrakii HM-1, W. saturnus toxin, P. anomala
PaKT and Z. bailii zygocin) have shown activity against pathogenic yeasts, such as Candida albicans,
Cryptococcus neoformans, etc., they have been suggested to be potentially useful as potential antifungal
agents for infections caused by fungi, their direct application is of limited real importance because of
their instability at physiological temperatures and pH values and their antigenicity [39,104,146–151].
Once again, only the killer toxins that display a remarkable stability (e.g., the Williopsis toxins) could be
therapeutically used, but restricted to topical applications such as on superficial skin infections [151].
In this context, the role and use of P. membranifaciens and its killer toxins to control human or animal
infections and other clinical diseases is still uncertain.
Since the use of P. membranifaciens killer toxins seems to be not really useful at clinical stages,
their use for biocontrol purposes has a great interest in agro-food industry. The applications of the
biocide activity of P. membranifaciens were initially unveiled by Masih et al. (2001), observing that the
mycelium of the B. cinerea treated with P. membranifaciens failed to develop the characteristic grey mould
symptoms when it was re-inoculated onto grapevine [152]. This destructive process was suggested
to be mediated by the production of exo- and endo-β-1,3-glucanases, as was also demonstrated by
Masih et al. (2002) [153]. However, as described by Santos and colleagues in both grapevine and apple
matrixes, this antagonistic phenomenon could also be mediated by killer toxin (PMKT) activity [19,154].
The co-existence of different mechanisms, including hydrolytic enzymes and killer toxin production, is
one of the reasons that justifies the interest and versatility of P. membranifaciens as a biocontrol agent
against B. cinerea, since it was also proved effective in postharvest pears [155].
The existence of similar and additional antagonistic mechanisms in other yeasts and their use to
control B. cinerea spoilage have also been reported. For example, the production of exo-glucanase toxins
in W. anomalus was reported by Parafati et al. (2016) [156], but the production of certain volatile organic
compounds (i.e., 2-phenylethanol) has also been suggested as determinant for the biocontrol activity
against B. cinerea found in this species and in others such as Candida intermedia, Sporidiobolus pararoseus,
Starmerella bacilaris and S. cerevisiae [157–162].
In a similar context, P. membranifaciens has also been used as a biological tool for the control of other
crop-fruit-associated fungus pathogens such as Penicillium expansum in postharvest peaches (by rapid
colonization and competition for space and nutrients in fruit wounds) [163] and in postharvest
pears (by nutrient and space competition and the production of chitinase, glucanase and other
killer activities) [155]; Colletotrichum acutatum causing anthracnose rot in postharvest loquat fruit
(by producing chitinase andβ-1,3-glucanase) [164]; Penicillium roqueforti in storage wheat grain (with no
conclusions about the mechanism of action) [160]; and Penicillium italicum, Penicillium digitatum and
Colletotrichum gloeosporioides causing blue and green mold and anthracnose in citrus fruit (with no
conclusions about the mechanism of action) [165].
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Table 3. Potential applications of killer toxins.
Applications Organism/s Toxin General Description References
Biological models Saccharomyces cerevisiae K28 Model for the study of proteins, lipids, and mechanisms required on endocytosisand retrograde trafficking in A/B toxins (as Ricin, Shiga, and Cholera toxins) [166]
Biotyping
Killer strains panel - Fingerprinting and clustering yeast strains (genera Debaryomyces, Kluyveromyces,Saccharomyces, and Zygosaccharomyces) by use of killer toxin sensitive patterns [167]
Saccharomyces cerevisiae - Typing S. cerevisiae strain by combined use of RAPD and killer toxin sensitivity patterns [168]
Cryptococcus laurentii (CBS 139) - Biotyping varieties of Cryptococcus neomorfans (var. neoformans and var. gattii)by differential killer toxin sensitivity patterns [169]
Killer strains panel - Combined use of mtDNA-RFLP patterns and killer toxin biotype tostudy wine S. cerevisiae strain diversity in different viticulture regions [170]
Killer strains panel - Fingerprinting of Saccharomyces wine yeast by differential killer sensitivity [171]
Pichia mrakii K9 Use Pichia genera killer toxins to differentiate members belonging to the
Nocardia asteroides complex (N. asteroides, N. farcinica, and N. nova)
[172]
Pichia lynferdii K76
Killer strains panel - Use of toxins produced by a selected panel of killer yeast to discriminatestrains belonging to genus Candida by their killer sensitive patterns [173]
Antimycotics for
the treatment of
human infections
Pichia anomala PaKT Using killer toxin-like anti-idiotypic antibodies of P. anomala killer toxin (PaKT-antilds)to treat treating human Pneumocystis carinii pneumonia. [174]
Zygosaccharomyces bailii Zygocin Antifungal effect of Zygocin, a killer toxin produced by Z. bailii, on a broad-spectrumof sensitive fungal cells (Candida, Pichia, Hanseniaspora, Fusarium genera) [104]
Kodamaea ohmeri
(HB55 and HB88) -
Inhibition of C. neoformans (vars. neoformans, grubii and gattii), both clinical and environmental
isolates, by two Brazilian yeasts selected for being able to inhibit human pathogenic fungi [175]
Filobasidium capsuligenum Fc-1 Use of a novel toxin with activity against the opportunistic fungal pathogen C. neoformans,as a therapeutic agent for the treatment of cryptococcosis [176]
Pichia anomala K10 MAbs Apply of antiidiotypic monoclonal antibodies (KT MAbs) from P. anomala against Aspergillus fumigatus. [177]
Williopsis mrakii var. mrakii
(IFO 0895) HM-1
Activity of the killer toxin HM-1 from W. markii var. mrakii
(formerly known as Hansenula mrakii) against Candida genus yeasts [147]
W. saturnus var. mrakii
(MUCL 41968) WmKT
Application of killer toxin (WmKT) secreted by W. saturnus var. mrakii,
which is active against a wide range of pathogens. [178]
Antimycotics for
treatment of
animal infections
Kluyveromyces siamensis
(HN12-1) -
Use of a killer toxin of K. siamensis against Metschnikowia bicuspidata WCY,
agent for the milky disease in crab [179]
Pichia anomala (YF07b) - Apply of a killer toxin produced by the marine yeast P. anomala,against pathogenic yeast cells in crab, artemia, and shrimp [68]
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Table 3. Cont.
Applications Organism/s Toxin General Description References
Prevention of
contaminants in
fermentation
industries
Saccharomyces cerevisiae - Effect of killer strains of S. cerevisiae on the growth of sensitive strains during wine fermentation,to improve the selected wine strain implantation. Sparkling wines quality improvement [180,181]
Kluyveromyces phaffii (DBVPG 6076) - Use of K. phaffii killer toxin to control apiculate spoilage wine yeast (Hanseniaspora uvarum) [182]
Torulaspora delbrueckii (NPCC 1033) TdKT Application of a novel killer toxin (TdKT) from T. delbrueckii as a biocontroltool in winemaking against different wine spoilage yeasts [9]
Ustilago maydis (CYC 1410) - Use of U. maydis toxins for the biocontrol of Brettanomyces bruxellensis for thereduction of aroma defects caused by this spoilage yeast [10]
Candida nodaensis (PYCC 3198) CnKT Application of CnKT in the preservation of salt-fermented foods, because of its high stability to salinity [45]
D. hansenii, K. marxianus, P. anomala,
P. guilliermondii, S. cerevisiae -
Control of olive table fermentation by the selection of killer yeast and their
toxins which are able to suppress indigenous spoilage yeast growth [86]
Williopsis saturnus var. saturnus - Use of W. saturnus var. saturnus to inhibit spoilage yeast, as S. cerevisiae and K. marxianus,as a biopreservative agent on cheese making (in laboratory conditions) [183]
Wickerhamomyces anomalus (D2) PiKT Application of KwKT killer toxin produced by K. wickerhamii and PiKT produced by
W. anomalus killer against B. bruxellensis during wine fermentation.
[184]
Kluyveromyces wickerhamii (D15) KwKT
Candida pyralidae (IWBT Y1140) CpKT1 Control of B. bruxellensis by C. pyralidae killer toxin in wine fermentation. [185]
Pichia membranifaciens PMKT Use of PMKT to control Zygosaccharomyces spp. contamination in winemaking. [186]
Wine quality
improvement
S. cerevisiae (AWRI 796) K2 Interaction of S. cerevisiae killer strain (AWRI 796) and sensitive strain (Tyr 303) toaccelerate the autolysis in the sparkling wine production to improve the final wine quality [187]
Wickerhamomyces anomalus
(CBS 1982, CBS5759) -
Application of W. anomalus and S. cerevisiae in a mixed culture to positively
influence chemical composition (higher amounts of polyphenol compounds and
lower amounts of malic acid) and sensory features of produced apple wines
[188]
Biological control
Kluyveromyces lactis (PCK27) - Use of killer strain K. lactis PCK27, to inhibit P. anomala, aerobic spoilage yeast in silage making [144]
Williopsis mrakii Mycocin HMK Utilization of killer toxin HMK of W. mrakii, expressed in Aspergillus niger,to control both silage spoilage and yoghurt spoilage caused by yeasts [90]
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The activity of P. membranifaciens towards the wine spoilage yeast B. bruxellensis was firstly
observed by Yap et al. (2000) [189], and this fact was later confirmed by Santos et al. (2009), who
verified the inhibition of P. membranifaciens CYC 1086 and its killer toxin PMKT2 against B. bruxellensis in
simulated winemaking conditions [20]. Apart from the use of P. membranifaciens CYC 1086 and PMKT2,
killer toxins from Ustilago maydis [10], Torulaspora delbrueckii (TdKT) [9], Kluyveromyces wickerhamii
(Kwkt), Wickerhamomyces anomalus (Pikt) [183] and Candida pyralidae (CpKT1) [184] and the production
of pulcherriminic acid by Metschnikowia pulcherrima (without a real killer activity but depleting
biologically available iron from the medium) [190] have been reported as useful to control Brettanomyces
spoilage. Continuing in the enology context, results from Alonso et al. (2015) and Labbani et al. (2015)
conclude that a synergistic effect was operating using PMKT [185] and Pkkp (from P. kluyveri) [8] killer
toxins, respectively, in combination with potassium metabisulfite, against wine spoilage yeasts such as
Zygosaccharomyces or Dekkera/Brettanomyces species. Recently, Velazquez and coworkers described the
utility of mixed-inoculation with killer and sensitive yeast strains to speed cell death during second
fermentation of sparkling-wines to release of certain compounds from autolyzed yeast cells [181].
In summary, the killer activity of P. membranifaciens shows a broad spectrum of potential
applications, sustained by a considerable diversity of mechanisms of action. However, a marked
lability of these killer toxins restricts their application to specific environments and matrixes providing
adequate chemical physical conditions. These requirements are basically found in food, post-harvest,
and fermentative environments, even though the industrial application of killer toxins is far from a
reality, since their large-scale production is still expensive. For this reason, the current tendency is only
based in applying killer yeasts instead of their toxins. Furthermore, killer resistant strains have been
described since the initial studies on killer toxins and, in many surveys, it is possible to found, over a
panel of potential sensitive yeast isolates, that some strains are resistant to that potential biocontrol
agents [20]. In accordance, these toxins could be less valuable for biocontrol in real applications.
For those purposes, regarding toxin stability in both production and application stages, adaptive
and directed evolution approaches are of great interest in the development and isolation of
phenotypically improved variants. It is possible to evolve populations in laboratory conditions,
where it is important that the selection conditions match the industrial parameters as closely as
possible [191]. Since temperature and pH are the main limiting factors, especially for clinical
applications, adaptive processes should be carried out with P. membranifaciens killer strains to obtain
toxins with increased stability at human physiological conditions. Additionally, killer toxins identified
as leads for therapeutic uses should also be modulated to reduce their antigenicity [192]. For that
purpose, the molecular structure and mechanism of action of P. membranifaciens killer toxins should be
studied in depth, in order to identify key residues causing toxicity and antigenicity, and determine
their stability. Finally, the cellular response of the target pathogenic/spoilage microorganism to killer
toxins needs to be studied species by species to understand the basis of their susceptibility.
Additional studies are currently under development to increase the background of knowledge
accumulated during the last two decades on the features of P. membranifaciens killer toxins, in the hope
of understanding how to work with these killer toxins that have potential biotechnological applications.
Elucidation of the molecular mechanisms of their action will be helpful to develop the strategies to
fight more and more harmful spoilage yeasts.
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